These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31831392)

  • 1. Endoscopic ultrasound may be used to deliver gene expression signatures using digital mRNA detection methods to immunophenotype pancreatic ductal adenocarcinoma to facilitate personalized immunotherapy.
    Gleeson FC; Levy MJ; Jackson RA; Murphy SJ; Halling KC; Kipp BR; Graham RP; Zhang L
    Pancreatology; 2020 Mar; 20(2):229-238. PubMed ID: 31831392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression profiling of morphologic subtypes of pancreatic ductal adenocarcinoma using surgical and EUS-FNB specimens.
    Rasmussen LG; Verbeke CS; Sørensen MD; Pfeiffer P; Tan Q; Mortensen MB; Fristrup C; Detlefsen S
    Pancreatology; 2021 Apr; 21(3):530-543. PubMed ID: 33637450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptomic-Based Microenvironment Classification Reveals Precision Medicine Strategies for Pancreatic Ductal Adenocarcinoma.
    George B; Kudryashova O; Kravets A; Thalji S; Malarkannan S; Kurzrock R; Chernyavskaya E; Gusakova M; Kravchenko D; Tychinin D; Savin E; Alekseeva L; Butusova A; Bagaev A; Shin N; Brown JH; Sethi I; Wang D; Taylor B; McFall T; Kamgar M; Hall WA; Erickson B; Christians KK; Evans DB; Tsai S
    Gastroenterology; 2024 May; 166(5):859-871.e3. PubMed ID: 38280684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoscopic ultrasound-guided tissue acquisition for pancreatic ductal adenocarcinoma in the era of precision medicine.
    Ashida R; Kitano M
    Dig Endosc; 2022 Nov; 34(7):1329-1339. PubMed ID: 35488448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.
    Wang WQ; Liu L; Xu HX; Wu CT; Xiang JF; Xu J; Liu C; Long J; Ni QX; Yu XJ
    Br J Surg; 2016 Aug; 103(9):1189-99. PubMed ID: 27256393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic ultrasound-guided injectable therapy for pancreatic cancer: A systematic review.
    Kaur J; Jaruvongvanich V; Chandrasekhara V
    World J Gastroenterol; 2022 Jun; 28(21):2383-2395. PubMed ID: 35800184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic ultrasound-guided fine-needle biopsy as a tool for studying the intra-tumoral microbiome in pancreatic ductal adenocarcinoma: a pilot study.
    Chu CS; Yang CY; Yeh CC; Lin RT; Chen CC; Bai LY; Hung MC; Lin CC; Wu CY; Lin JT
    Sci Rep; 2022 Jan; 12(1):107. PubMed ID: 34997106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synchronous Pancreatic Ductal Adenocarcinomas Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Biopsy.
    Goong HJ; Moon JH; Choi HJ; Lee YN; Choi MH; Kim HK; Lee TH; Cha SW
    Gut Liver; 2015 Sep; 9(5):685-8. PubMed ID: 26087782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
    Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
    J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A deep learning model to detect pancreatic ductal adenocarcinoma on endoscopic ultrasound-guided fine-needle biopsy.
    Naito Y; Tsuneki M; Fukushima N; Koga Y; Higashi M; Notohara K; Aishima S; Ohike N; Tajiri T; Yamaguchi H; Fukumura Y; Kojima M; Hirabayashi K; Hamada Y; Norose T; Kai K; Omori Y; Sukeda A; Noguchi H; Uchino K; Itakura J; Okabe Y; Yamada Y; Akiba J; Kanavati F; Oda Y; Furukawa T; Yano H
    Sci Rep; 2021 Apr; 11(1):8454. PubMed ID: 33875703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
    Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
    J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a patient-specific avatar organoid model derived from EUS-guided fine-needle biopsy for timely clinical application in pancreatic ductal adenocarcinoma (with video).
    Kim H; Jang J; Choi JH; Song JH; Lee SH; Park J; Ryoo SK; Lee EM; Jeong HO; Kim S; Lee SH; Lee KH; Lee KT; Kim KM; Jang KT; Lee H; Lee S; Lee JK; Park JK
    Gastrointest Endosc; 2024 Jul; 100(1):85-96.e9. PubMed ID: 38447660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardized Methods Using EUS-guided Fine-needle Biopsy and a Minimal Medium Creates Three Pancreatic Cancer Organoids.
    Ishida Y; Tsunoda T; Hamada Y; Tsuchiya N; Koga T; Kitaguchi T; Matsumoto K; Matsumoto S; Sasaki T; Nakashima R; Ishii F; Kajiwara M; Shirasawa S; Hasegawa S; Hirai F
    Anticancer Res; 2022 Aug; 42(8):4103-4109. PubMed ID: 35896269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver agreement and accuracy of preoperative endoscopic ultrasound-guided biopsy for histological grading of pancreatic cancer.
    Larghi A; Correale L; Ricci R; Abdulkader I; Monges G; Iglesias-Garcia J; Giovannini M; Attili F; Vitale G; Hassan C; Costamagna G; Rindi G
    Endoscopy; 2015 Apr; 47(4):308-14. PubMed ID: 25521572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
    Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
    Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EUS-guided reverse bevel fine-needle biopsy sampling and open tip fine-needle aspiration in solid pancreatic lesions - a prospective, comparative study.
    Hedenström P; Demir A; Khodakaram K; Nilsson O; Sadik R
    Scand J Gastroenterol; 2018 Feb; 53(2):231-237. PubMed ID: 29301477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Immunological Glance on Pancreatic Ductal Adenocarcinoma.
    Melzer MK; Arnold F; Stifter K; Zengerling F; Azoitei N; Seufferlein T; Bolenz C; Kleger A
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, Validation, and Utilization of Immune Cells in Pancreatic Ductal Adenocarcinoma Based on Marker Genes.
    de Koning W; Latifi D; Li Y; van Eijck CHJ; Stubbs AP; Mustafa DAM
    Front Immunol; 2021; 12():649061. PubMed ID: 33986743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gene expression signature for predicting response to neoadjuvant chemoradiotherapy in pancreatic ductal adenocarcinoma.
    Nishiwada S; Sho M; Cui Y; Yamamura K; Akahori T; Nakagawa K; Nagai M; Nakamura K; Takagi T; Ikeda N; Li W; Baba H; Goel A
    Int J Cancer; 2021 Feb; 148(3):769-779. PubMed ID: 32895958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational combinations of immunotherapy for pancreatic ductal adenocarcinoma.
    Blair AB; Zheng L
    Chin Clin Oncol; 2017 Jun; 6(3):31. PubMed ID: 28705008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.